PMID- 30745295
OWN - NLM
STAT- MEDLINE
DCOM- 20190409
LR  - 20190409
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 364
DP  - 2019 Feb 11
TI  - Postmenopausal hormone therapy and risk of venous thromboembolism: what about
      progesterone?
PG  - l601
LID - 10.1136/bmj.l601 [doi]
FAU - Scarabin, Pierre-Yves
AU  - Scarabin PY
AD  - Inserm U1018, Hopital Paul Brousse, 94807 Villejuif, France.
LA  - eng
PT  - Letter
PT  - Comment
DEP - 20190211
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
RN  - 4G7DS2Q64Y (Progesterone)
SB  - AIM
SB  - IM
CON - BMJ. 2019 Jan 9;364:k4810. PMID: 30626577
EIN - BMJ. 2019 Feb 19;364:l694. PMID: 30782600
MH  - Case-Control Studies
MH  - Estrogen Replacement Therapy
MH  - Hormone Replacement Therapy
MH  - Humans
MH  - Postmenopause
MH  - *Progesterone
MH  - *Venous Thromboembolism
COIS- Competing interests: None declared.
EDAT- 2019/02/13 06:00
MHDA- 2019/04/10 06:00
CRDT- 2019/02/13 06:00
PHST- 2019/02/13 06:00 [entrez]
PHST- 2019/02/13 06:00 [pubmed]
PHST- 2019/04/10 06:00 [medline]
AID - 10.1136/bmj.l601 [doi]
PST - epublish
SO  - BMJ. 2019 Feb 11;364:l601. doi: 10.1136/bmj.l601.